Skip to Content

M L 25 (Lisinopril 20 mg)

Pill with imprint M L 25 is Yellow, Round and has been identified as Lisinopril 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L 25

Lisinopril 20 mg M L 25
Lisinopril 20 mg M L 25
Lisinopril 20 mg M L 25
Lisinopril 20 mg M L 25 Front
Lisinopril 20 mg M L 25 Back
Lisinopril 20 mg M L 25

Lisinopril

Imprint
M L 25
Strength
20 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, calcium phosphate dihydrate dibasic, magnesium stearate, mannitol, povidone, corn starch, sodium lauryl sulfate, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-2075 Mylan Pharmaceuticals Inc.
51079-0983 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M L 25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.